MedTrace Logo

The Influence of Glycemic Control and Obesity on Energy Balance and Metabolic Flexibility in Type 1 Diabetes

NCT03379792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2024-01-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to measure the metabolic phenotype of a range of body weights in individuals with and without type 1 diabetes.

Conditions

Sponsors & Collaborators

  • AdventHealth Translational Research Institute

    lead OTHER

Principal Investigators

  • Richard Pratley, MD · Translational Research Institute for Metabolism and Diabetes

  • Elizabeth Mayer-Davis, PhD · UNC Chapel Hill

  • David M Maahs, MD, PhD · Stanford University

Eligibility

Min Age
19 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-08
Primary Completion
2020-07-20
Completion
2020-07-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03379792 on ClinicalTrials.gov